Neumann FJ, Sousa-Uva M, Ahlsson A, Alfonso F, Banning AP, Benedetto U, et al. 2018 ESC/EACTS guidelines on myocardial revascularization. Eur Heart J. 2019;40(2):87–165.

Article  Google Scholar 

Latib A, Colombo A, Castriota F, Micari A, Cremonesi A, De Felice F, et al. A randomized multicenter study comparing a paclitaxel drug-eluting balloon with a paclitaxel-eluting stent in small coronary vessels: the BELLO (Balloon Elution and Late Loss Optimization) study. J Am Coll Cardiol. 2012;60(24):2473–80.

CAS  Article  Google Scholar 

Unverdorben M, Kleber FX, Heuer H, Figulla H-R, Vallbracht C, Leschke M, et al. Treatment of small coronary arteries with a paclitaxel-coated balloon catheter in the PEPCAD I study are lesions clinically stable from 12 to 36 months. EuroIntervention. 2013;9:620–8.

Article  Google Scholar 

Cortese B, Micheli A, Picchi A, Coppolaro A, Bandinelli L, Severi S, et al. Paclitaxel-coated balloon versus drug-eluting stent during PCI of small coronary vessels, a prospective randomised clinical trial. The PICCOLETO study. Heart. 2010;96(16):1291–6.

Article  Google Scholar 

Scheller B, Speck U, Schmitt A, Böhm M, Nickenig G. Addition of paclitaxel to contrast media prevents restenosis after coronary stent implantation. J Am Coll Cardiol. 2003;42(8):1415–20.

CAS  Article  Google Scholar 

Jeger RV, Farah A, Ohlow M-A, Mangner N, Möbius-Winkler S, Leibundgut G, et al. Drug-coated balloons for small coronary artery disease (BASKET-SMALL 2): an open-label randomised non-inferiority trial. Lancet. 2018;392(10150):849–56.

CAS  Article  Google Scholar 

Tang Y, Qiao S, Su X, Chen Y, Jin Z, Chen H, et al. Drug-coated balloon versus drug-eluting stent for small-vessel disease: the RESTORE SVD China randomized trial. JACC Cardiovasc Interv. 2018;11(23):2381–92.

Article  Google Scholar 

Yu X, Ji F, Xu F, Zhang W, Wang X, Lu D, et al. Treatment of large de novo coronary lesions with paclitaxel-coated balloon only: results from a Chinese institute. Clin Res Cardiol. 2019;108(3):234–43.

CAS  Article  Google Scholar 

Liu Y, Zhang YJ, Deng LX, Yin ZY, Hu T, Wang Q, et al. 12-month clinical results of drug-coated balloons for de novo coronary lesion in vessels exceeding 3.0 mm. Int J Card Imaging. 2019;35(4):579–86.

Article  Google Scholar 

Lu W, Zhu Y, Han Z, Sun G, Qin X, Wang Z, et al. Short-term outcomes from drug-coated balloon for coronary de novo lesions in large vessels. J Cardiol. 2019;73(2):151–5.

Article  Google Scholar 

Nishiyama N, Komatsu T, Kuroyanagi T, Fujikake A, Komatsu S, Nakamura H, et al. Clinical value of drug-coated balloon angioplasty for de novo lesions in patients with coronary artery disease. Int J Cardiol. 2016;222:113–8.

Article  Google Scholar 

Holmes DR, Holubkov R, Vlietstra RE, Kelsey SF, Reeder GS, Dorros G, et al. Comparison of complications during percutaneous transluminal coronary angioplasty from 1977 to 1981 and from 1985 to 1986:The national heart,lung,and blood institue percutaneous transluminal coronary angioplasty registry. J Am Coll Cardiol. 1988;12(5):1149–55.

Article  Google Scholar 

Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD, et al. Third universal definition of myocardial infarction. J Am Coll Cardiol. 2012;60(16):1581–98.

Article  Google Scholar 

Cutlip DE, Windecker S, Mehran R, Boam A, Cohen DJ, van Es GA, et al. Clinical end points in coronary stent trials: a case for standardized definitions. Circulation. 2007;115(17):2344–51.

Article  Google Scholar 

Kleber FX, Rittger H, Bonaventura K, Zeymer U, Wohrle J, Jeger R, et al. Drug-coated balloons for treatment of coronary artery disease: updated recommendations from a consensus group. Clin Res Cardiol. 2013;102(11):785–97.

CAS  Article  Google Scholar 

Chen Y, Wang J, Liu B, Ji F, Qiu C, Qiao S. Clinical use of drug-coated balloon: recommendations by the Chinese consensus group. Chin J Intervent Cardiol. 2016;24(2):61–7.

Google Scholar 

Waksman R, Serra A, Loh JP, Malik FT-N, Torguson R, Stahnke S. Strandmann RPv, Rodriguez AE: Drug-coated balloons for de novo coronary lesions results from the Valentines II trial. EuroIntervention. 2013;9:613–9.

Article  Google Scholar 

Ann SH, Her AY, Singh GB, Okamura T, Koo BK, Shin ES. Serial morphological and functional assessment of the paclitaxel-coated balloon for de novo lesions. Rev Esp Cardiol (Engl Ed). 2016;69(11):1026–32.

Article  Google Scholar 

Jensen CJ, Richardt G, Tolg R, Erglis A, Skurk C, Jung W, et al. Angiographic and clinical performance of a paclitaxel-coated balloon compared to a second-generation sirolimus-eluting stent in patients with in-stent restenosis: the BIOLUX randomised controlled trial. EuroIntervention. 2018;14(10):1096–103.

Article  Google Scholar 

Brener SJ, Prasad AJ, Khan Z, Sacchi TJ. The relationship between late lumen loss and restenosis among various drug-eluting stents: a systematic review and meta-regression analysis of randomized clinical trials. Atherosclerosis. 2011;214(1):158–62.

CAS  Article  Google Scholar 

Xu B, Yang Y, Yuan Z, Du Z, Wong SC, Genereux P, et al. Zotarolimus- and paclitaxel-eluting stents in an all-comer population in China: the RESOLUTE China randomized controlled trial. JACC Cardiovasc Interv. 2013;6(7):664–70.

Article  Google Scholar 

Cassese S, Byrne RA, Ndrepepa G, Kufner S, Wiebe J, Repp J, et al. Everolimus-eluting bioresorbable vascular scaffolds versus everolimus-eluting metallic stents: a meta-analysis of randomised controlled trials. Lancet. 2016;387(10018):537–44.

CAS  Article  Google Scholar 

Pleva L, Kukla P, Kusnierova P, Zapletalova J, Hlinomaz O. Comparison of the efficacy of paclitaxel-eluting balloon catheters and everolimus-eluting stents in the treatment of coronary in-stent restenosis: the treatment of in-stent restenosis study. Circ Cardiovasc Interv. 2016;9(4):e003316.

CAS  Article  Google Scholar 

Qiu J, Han ZY, Wang X, Lu WJ, Pan L, Sun GJ, et al. Outcomes of patients treated with drug-coated balloons for de novo large coronary vessels. Zhonghua Xin Xue Guan Bing Za Zhi. 2019;47(6):452–6.

CAS  PubMed  Google Scholar 

Pocock SJ, Lansky AJ, Mehran R, Popma JJ, Fahy MP, Na Y, et al. Angiographic surrogate end points in drug-eluting stent trials: a systematic evaluation based on individual patient data from 11 randomized, controlled trials. J Am Coll Cardiol. 2008;51(1):23–32.

Article  Google Scholar 

Her AY, Shin ES, Bang LH, Nuruddin AA, Tang Q, Hsieh IC, et al. Drug-coated balloon treatment in coronary artery disease: recommendations from an Asia-Pacific Consensus Group. Cardiol J. 2019;28:136–49.

Article  Google Scholar 

Jeger RV, Eccleshall S, Wan Ahmad WA, Ge J, Poerner TC, Shin E-S, et al. Drug-coated balloons for coronary artery disease. J Am Coll Cardiol Intv. 2020;13(12):1391–402.

Article  Google Scholar 

Scheller B, Speck U, Abramjuk C, Bernhardt U, Bohm M, Nickenig G. Paclitaxel balloon coating, a novel method for prevention and therapy of restenosis. Circulation. 2004;110(7):810–4.

CAS  Article  Google Scholar 

Hermans WR, Rensing BJ, Foley DP, Deckers JW, Rutsch W, Emanuelsson H, et al. Therapeutic dissection after successful coronary balloon angioplasty: no influence on restenosis or on clinical outcome in 693 patients. The MERCATOR Study Group (Multicenter European Research Trial with Cilazapril after Angioplasty to prevent Transluminal Coronary Obstruction and Restenosis). J Am Coll Cardiol. 1992;20(4):767–80.

CAS  Article  Google Scholar 

Bourassa MG, Lespérance J, Eastwood C, Schwartz L, Cöté G, Kazim F, et al. Clinical, physiologic, anatomic and procedural factors predictive of restenosis after percutaneous transluminal coronary angioplasty. J Am Coll Cardiol. 1991;18(2):368–76.

CAS  Article  Google Scholar 

Sogabe K, Koide M, Fukui K, Kato Y, Kitajima H, Akabame S, Zen K, Nakamura T, Matoba S. Optical coherence tomography analysis of late lumen enlargement after paclitaxel-coated balloon angioplasty for de-novo coronary artery disease. Catheter Cardiovasc Interv. 2020. https://doi.org/10.1002/ccd.29435.

Onishi T, Onishi Y, Kobayashi I, Sato Y. Late lumen enlargement after drug-coated balloon angioplasty for de novo coronary artery disease. Cardiovasc Interv Ther. 2020 Jul 9. doi: 10.1007/s12928-020-00690-2. Epub ahead of print. Erratum in: Cardiovasc Interv Ther. 2020.